These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31619700)

  • 1. Short-Long Heart Rate Variation Increases Dispersion of Action Potential Duration in Long QT Type 2 Transgenic Rabbit Model.
    Kim TY; Jeng P; Hwang J; Pfeiffer Z; Patel D; Cooper LL; Kossidas K; Centracchio J; Peng X; Koren G; Qu Z; Choi BR
    Sci Rep; 2019 Oct; 9(1):14849. PubMed ID: 31619700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits.
    Odening KE; Jung BA; Lang CN; Cabrera Lozoya R; Ziupa D; Menza M; Relan J; Franke G; Perez Feliz S; Koren G; Zehender M; Bode C; Brunner M; Sermesant M; Föll D
    Heart Rhythm; 2013 Oct; 10(10):1533-41. PubMed ID: 23892340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome.
    Ziv O; Morales E; Song YK; Peng X; Odening KE; Buxton AE; Karma A; Koren G; Choi BR
    J Physiol; 2009 Oct; 587(Pt 19):4661-80. PubMed ID: 19675070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pronounced effects of HERG-blockers E-4031 and erythromycin on APD, spatial APD dispersion and triangulation in transgenic long-QT type 1 rabbits.
    Ziupa D; Beck J; Franke G; Perez Feliz S; Hartmann M; Koren G; Zehender M; Bode C; Brunner M; Odening KE
    PLoS One; 2014; 9(9):e107210. PubMed ID: 25244401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological studies of transgenic long QT type 1 and type 2 rabbits reveal genotype-specific differences in ventricular refractoriness and His conduction.
    Odening KE; Kirk M; Brunner M; Ziv O; Lorvidhaya P; Liu GX; Schofield L; Chaves L; Peng X; Zehender M; Choi BR; Koren G
    Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H643-55. PubMed ID: 20581090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization.
    Odening KE; Hyder O; Chaves L; Schofield L; Brunner M; Kirk M; Zehender M; Peng X; Koren G
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2264-72. PubMed ID: 18835916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential conditions for early after-depolarizations and triggered activity in cardiomyocytes derived from transgenic LQT1 and LQT2 rabbits.
    Liu GX; Choi BR; Ziv O; Li W; de Lange E; Qu Z; Koren G
    J Physiol; 2012 Mar; 590(5):1171-80. PubMed ID: 22183728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms linking T-wave alternans to spontaneous initiation of ventricular arrhythmias in rabbit models of long QT syndrome.
    Liu W; Kim TY; Huang X; Liu MB; Koren G; Choi BR; Qu Z
    J Physiol; 2018 Apr; 596(8):1341-1355. PubMed ID: 29377142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicorandil normalizes prolonged repolarisation in the first transgenic rabbit model with Long-QT syndrome 1 both in vitro and in vivo.
    Biermann J; Wu K; Odening KE; Asbach S; Koren G; Peng X; Zehender M; Bode C; Brunner M
    Eur J Pharmacol; 2011 Jan; 650(1):309-16. PubMed ID: 20959120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analyses of transgenic LQT1 and LQT2 rabbit hearts elucidate an increase in expression and activity of energy producing enzymes.
    Jindal HK; Merchant E; Balschi JA; Zhangand Y; Koren G
    J Proteomics; 2012 Sep; 75(17):5254-65. PubMed ID: 22796357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome.
    Tanabe Y; Inagaki M; Kurita T; Nagaya N; Taguchi A; Suyama K; Aihara N; Kamakura S; Sunagawa K; Nakamura K; Ohe T; Towbin JA; Priori SG; Shimizu W
    J Am Coll Cardiol; 2001 Mar; 37(3):911-9. PubMed ID: 11693770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2.
    Giannetti F; Barbieri M; Shiti A; Casini S; Sager PT; Das S; Pradhananga S; Srinivasan D; Nimani S; Alerni N; Louradour J; Mura M; Gnecchi M; Brink P; Zehender M; Koren G; Zaza A; Crotti L; Wilde AAM; Schwartz PJ; Remme CA; Gepstein L; Sala L; Odening KE
    Europace; 2023 May; 25(5):. PubMed ID: 37099628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 2000 Aug; 102(6):706-12. PubMed ID: 10931813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.
    Shimizu W; Antzelevitch C
    J Electrocardiol; 1999; 32 Suppl():177-84. PubMed ID: 10688323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory electrocardiographic evidence of transmural dispersion of repolarization in patients with long-QT syndrome type 1 and 2.
    Viitasalo M; Oikarinen L; Swan H; Väänänen H; Glatter K; Laitinen PJ; Kontula K; Barron HV; Toivonen L; Scheinman MM
    Circulation; 2002 Nov; 106(19):2473-8. PubMed ID: 12417545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid normalizes QT interval in long QT type 2 transgenic rabbit models in a genotype-specific fashion.
    Castiglione A; Hornyik T; Wülfers EM; Giammarino L; Edler I; Jowais JJ; Rieder M; Perez-Feliz S; Koren G; Bősze Z; Varró A; Zehender M; Brunner M; Bode C; Liin SI; Larsson HP; Baczkó I; Odening KE
    Europace; 2022 Mar; 24(3):511-522. PubMed ID: 34601592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits.
    Bentzen BH; Bahrke S; Wu K; Larsen AP; Odening KE; Franke G; Storm vańs Gravesande K; Biermann J; Peng X; Koren G; Zehender M; Bode C; Grunnet M; Brunner M
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):223-30. PubMed ID: 21135701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phenylephrine provocation on dispersion of repolarization in congenital long QT syndrome.
    Khositseth A; Nemec J; Hejlik J; Shen WK; Ackerman MJ
    Ann Noninvasive Electrocardiol; 2003 Jul; 8(3):208-14. PubMed ID: 14510655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of epinephrine on right ventricular monophasic action potentials in the LQT1 versus LQT2 form of long QT syndrome: preferential enhancement of "triangulation" in LQT1.
    Viitasalo M; Paavonen KJ; Swan H; Kontula K; Toivonen L
    Pacing Clin Electrophysiol; 2005 Mar; 28(3):219-27. PubMed ID: 15733182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome.
    Shimizu W; Tanabe Y; Aiba T; Inagaki M; Kurita T; Suyama K; Nagaya N; Taguchi A; Aihara N; Sunagawa K; Nakamura K; Ohe T; Towbin JA; Priori SG; Kamakura S
    J Am Coll Cardiol; 2002 Jun; 39(12):1984-91. PubMed ID: 12084597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.